LivaNova, Inc. has a policy against engaging in any activity which could be misconstrued as promoting our products for indications or uses other than those covered by our product approval by the local Healthcare Authority. Nevertheless,
LivaNova, Inc. recognizes it has a responsibility to provide licensed healthcare professionals, upon an unsolicited request, information on our product(s) that may fall outside the scope of our approved product labelling. In the space provided below, please provide your contact information and the topic of interest for which you are requesting information.
The information provided below are collected with the scope to respond to this specific request and LivaNova, Inc does not request personal information on patients to answer at this medical request. For more information about your privacy rights, please refer to our privacy notice.
INTENDED USE / INDICATIONS
Epilepsy ‐ The VNS Therapy System™ is indicated for use as an adjunctive therapy in reducing the frequency of seizures in patients whose epileptic disorder is dominated by partial seizures (with or without secondary generalization) or generalized seizures that are refractory to seizure medications.
Depression ‐ The VNS Therapy System™ is indicated for the treatment of chronic or recurrent depression in patients that are in a treatment-resistant or treatment intolerant major depressive episode.